Breaking News Instant updates and real-time market news.

BHF

Brighthouse Financial

$49.27 /

+2.27 (+4.83%)

17:41
12/02/21
12/02
17:41
12/02/21
17:41

Brighthouse Financial initiated with a Neutral at Goldman Sachs

Goldman Sachs analyst Alex Scott initiated coverage of Brighthouse Financial with a Neutral rating and $57 price target. The analyst said optimism around the excess capital position and strong RBC ratio in Brighthouse's statutory entities is offset by potentially large GAAP accounting adjustments and uncertainty around NAIC variable annuity reserves over the long term.

OTHER BREAKING NEWS FROM THE FLY

Recommendations
GT Biopharma price target lowered to $18 from $26 at B. Riley » 08:01
01/24/22
01/24
08:01
01/24/22
08:01
GTBP

GT Biopharma

$2.65 /

-0.04 (-1.49%)

B. Riley analyst Justin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTBP GT Biopharma
$2.65 /

-0.04 (-1.49%)

GTBP GT Biopharma
$2.65 /

-0.04 (-1.49%)

06/24/21 B. Riley
GT Biopharma price target raised to $26 from $21 at B. Riley
05/24/21 H.C. Wainwright
GT Biopharma initiated with a Buy at H.C. Wainwright
04/13/21 B. Riley
B. Riley starts GT Biopharma with Buy, sees 101% upside in shares
04/13/21 B. Riley
GT Biopharma initiated with a Buy at B. Riley
GTBP GT Biopharma
$2.65 /

-0.04 (-1.49%)

  • 11
    Feb
Recommendations
Frequency Therapeutics price target lowered to $17 from $21 at B. Riley » 08:01
01/24/22
01/24
08:01
01/24/22
08:01
FREQ

Frequency Therapeutics

$4.83 /

-0.12 (-2.42%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FREQ Frequency Therapeutics
$4.83 /

-0.12 (-2.42%)

FREQ Frequency Therapeutics
$4.83 /

-0.12 (-2.42%)

09/22/21 Goldman Sachs
Frequency Therapeutics downgraded to Neutral from Buy at Goldman Sachs
05/17/21 B. Riley
Frequency Therapeutics price target lowered to $21 from $35 at B. Riley
03/24/21 B. Riley Securities
Frequency Therapeutics price target lowered to $35 from $79 at B. Riley
03/24/21 Oppenheimer
Frequency Therapeutics price target lowered to $20 from $68 at Oppenheimer
FREQ Frequency Therapeutics
$4.83 /

-0.12 (-2.42%)

Recommendations
Entera Bio price target lowered to $6 from $11 at B. Riley » 08:01
01/24/22
01/24
08:01
01/24/22
08:01
ENTX

Entera Bio

$2.40 /

-0.03 (-1.23%)

B. Riley analyst Kalpit…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ENTX Entera Bio
$2.40 /

-0.03 (-1.23%)

ENTX Entera Bio
$2.40 /

-0.03 (-1.23%)

01/06/22 B. Riley
B. Riley 'puzzled' by Entera Bio selloff after FDA agreement
10/07/21 B. Riley
Entera Bio price target lowered to $11 from $14 at B. Riley
06/24/21 B. Riley
Entera Bio price target raised to $14 from $9 at B. Riley
06/16/21 B. Riley
Entera Bio initiated with a Buy, $9 target at B. Riley
ENTX Entera Bio
$2.40 /

-0.03 (-1.23%)

Recommendations
Eloxx Pharmaceuticals price target lowered to $3 from $5 at B. Riley » 08:00
01/24/22
01/24
08:00
01/24/22
08:00
ELOX

Eloxx Pharmaceuticals

/

+

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ELOX Eloxx Pharmaceuticals
/

+

ELOX Eloxx Pharmaceuticals
/

+

12/16/21 Oppenheimer
Oppenheimer starts 'intriguing' Eloxx at Outperform with $4 price target
12/16/21 Oppenheimer
Eloxx Pharmaceuticals initiated with an Outperform at Oppenheimer
11/18/21 H.C. Wainwright
Eloxx price target lowered to $1 from $2 at H.C. Wainwright
11/11/21 H.C. Wainwright
Eloxx Pharmaceuticals price target lowered to $2 from $3 at H.C. Wainwright
ELOX Eloxx Pharmaceuticals
/

+

  • 14
    May
Recommendations
Cognition Therapeutics price target lowered to $20 from $27 at B. Riley » 08:00
01/24/22
01/24
08:00
01/24/22
08:00
CGTX

Cognition Therapeutics

$3.63 /

-0.36 (-9.02%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CGTX Cognition Therapeutics
$3.63 /

-0.36 (-9.02%)

CGTX Cognition Therapeutics
$3.63 /

-0.36 (-9.02%)

11/03/21
Fly Intel: Top five analyst initiations
11/03/21 B. Riley
Cognition Therapeutics initiated with a Buy at B. Riley
11/03/21 Oppenheimer
Cognition Therapeutics initiated with an Outperform at Oppenheimer
CGTX Cognition Therapeutics
$3.63 /

-0.36 (-9.02%)

  • 08
    Oct
CGTX Cognition Therapeutics
$3.63 /

-0.36 (-9.02%)

Recommendations
BioVie price target lowered to $18 from $27 at B. Riley » 08:00
01/24/22
01/24
08:00
01/24/22
08:00
BIVI

BioVie

$4.02 /

-0.61 (-13.19%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIVI BioVie
$4.02 /

-0.61 (-13.19%)

BIVI BioVie
$4.02 /

-0.61 (-13.19%)

11/30/21 B. Riley
BioVie price target lowered to $27 from $50 at B. Riley
05/25/21 B. Riley
BioVie price target raised to $50 from $47 at B. Riley
  • 09
    Aug
BIVI BioVie
$4.02 /

-0.61 (-13.19%)

Recommendations
Altimmune price target lowered to $21 from $27 at B. Riley » 08:00
01/24/22
01/24
08:00
01/24/22
08:00
ALT

Altimmune

$7.00 /

+0.025 (+0.36%)

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$7.00 /

+0.025 (+0.36%)

ALT Altimmune
$7.00 /

+0.025 (+0.36%)

12/29/21 Jefferies
Altimmune assumed with a Buy at Jefferies
11/10/21 B. Riley
B. Riley keeps Buy rating on Altimmune, says 'valuation disconnect puzzling'
11/10/21 Piper Sandler
Piper says Altimmune NAFLD data for pemvidutide 'unprecedented'
10/04/21 Piper Sandler
Altimmune news provides opportunity to own shares, says Piper Sandler
ALT Altimmune
$7.00 /

+0.025 (+0.36%)

ALT Altimmune
$7.00 /

+0.025 (+0.36%)

ALT Altimmune
$7.00 /

+0.025 (+0.36%)

Options
Healthcare Trust call buyer realizes 86% same-day gains » 08:00
01/24/22
01/24
08:00
01/24/22
08:00
HTA

Healthcare Trust

$31.58 /

-0.105 (-0.33%)

Notable profits for the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HTA Healthcare Trust
$31.58 /

-0.105 (-0.33%)

HTA Healthcare Trust
$31.58 /

-0.105 (-0.33%)

12/14/21 Citi
Healthcare Trust downgraded to Neutral from Buy at Citi
11/24/21 Berenberg
Healthcare Trust downgraded to Hold from Buy at Berenberg
10/12/21 Stifel
Healthcare Trust price target raised to $35 from $32 at Stifel
10/07/21 BMO Capital
Healthcare Trust price target raised to $35 from $32.50 at BMO Capital
HTA Healthcare Trust
$31.58 /

-0.105 (-0.33%)

HTA Healthcare Trust
$31.58 /

-0.105 (-0.33%)

HTA Healthcare Trust
$31.58 /

-0.105 (-0.33%)

Recommendations
Allena Pharmaceuticals price target lowered to $3 from $4 at B. Riley » 07:59
01/24/22
01/24
07:59
01/24/22
07:59
ALNA

Allena Pharmaceuticals

/

+

B. Riley analyst Mayank…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

08/18/21 B. Riley
Allena Pharmaceuticals price target lowered to $4 from $5 at B. Riley
08/11/21 H.C. Wainwright
Allena Pharmaceuticals price target raised to $11 from $10 at H.C. Wainwright
ALNA Allena Pharmaceuticals
/

+

ALNA Allena Pharmaceuticals
/

+

Upgrade
Infinera upgraded to Buy with $11.50 target at B. Riley » 07:58
01/24/22
01/24
07:58
01/24/22
07:58
INFN

Infinera

$7.96 /

-0.31 (-3.75%)

B. Riley analyst Dave…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
INFN Infinera
$7.96 /

-0.31 (-3.75%)

INFN Infinera
$7.96 /

-0.31 (-3.75%)

04:43 Today B. Riley
Infinera upgraded to Buy from Neutral at B. Riley
01/21/22 B. Riley
Ribbon Communications should be bought on weakness, says B. Riley
10/18/21 JPMorgan
Infinera downgraded to Underweight on supply chain risk at JPMorgan
10/18/21 JPMorgan
Infinera downgraded to Underweight from Neutral at JPMorgan
INFN Infinera
$7.96 /

-0.31 (-3.75%)

INFN Infinera
$7.96 /

-0.31 (-3.75%)

Recommendations
Natera's Signatera trial results appear meaningful, says Canaccord » 07:55
01/24/22
01/24
07:55
01/24/22
07:55
NTRA

Natera

$62.74 /

-0.355 (-0.56%)

Canaccord analyst Kyle…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTRA Natera
$62.74 /

-0.355 (-0.56%)

NTRA Natera
$62.74 /

-0.355 (-0.56%)

07:10 Today Wells Fargo
Natera price target lowered to $100 from $135 at Wells Fargo
01/12/22 BTIG
Natera price target lowered to $150, named one of top 2022 picks at BTIG
01/05/22 Piper Sandler
Natera assumed with an Overweight at Piper Sandler
01/04/22 Canaccord
Natera weakness a buying opportunity, says Canaccord
NTRA Natera
$62.74 /

-0.355 (-0.56%)

  • 22
    Jul
NTRA Natera
$62.74 /

-0.355 (-0.56%)

General news
Treasury Market Outlook: stocks are broadly lower » 07:55
01/24/22
01/24
07:55
01/24/22
07:55
$ECON

Economic Data

/

+

Treasury Market Outlook:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

$ECON Economic Data
/

+

Recommendations
SVB Financial price target lowered to $700 from $790 at Stephens » 07:53
01/24/22
01/24
07:53
01/24/22
07:53
SIVB

SVB Financial

$582.22 /

-66.63 (-10.27%)

Stephens analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$582.22 /

-66.63 (-10.27%)

SIVB SVB Financial
$582.22 /

-66.63 (-10.27%)

01/21/22 Janney Montgomery Scott
SVB Financial downgraded to Neutral from Buy at Janney Montgomery Scott
01/13/22 Morgan Stanley
NatWest Group, SVB Financial added as top bank picks at Morgan Stanley
01/10/22 Morgan Stanley
SVB Financial assumed with an Overweight at Morgan Stanley
01/10/22 Odeon Capital
SVB Financial downgraded to Hold from Buy at Odeon Capital
SIVB SVB Financial
$582.22 /

-66.63 (-10.27%)

  • 10
    Aug
  • 23
    Mar
SIVB SVB Financial
$582.22 /

-66.63 (-10.27%)

SIVB SVB Financial
$582.22 /

-66.63 (-10.27%)

Initiation
Carbon Streaming initiated with a Strong Buy at Raymond James » 07:53
01/24/22
01/24
07:53
01/24/22
07:53
OFSTF

Carbon Streaming

$10.33 /

-0.7177 (-6.50%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Hot Stocks
Digital Ally's Nobility Healthcare acquires billing company for $2.1M » 07:49
01/24/22
01/24
07:49
01/24/22
07:49
DGLY

Digital Ally

$1.04 /

+0.01 (+0.97%)

Digital Ally announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DGLY Digital Ally
$1.04 /

+0.01 (+0.97%)

DGLY Digital Ally
$1.04 /

+0.01 (+0.97%)

01/18/22 EF Hutton
Digital Ally initiated with a Buy at EF Hutton
DGLY Digital Ally
$1.04 /

+0.01 (+0.97%)

DGLY Digital Ally
$1.04 /

+0.01 (+0.97%)

Upgrade
FirstService upgraded to Outperform from Market Perform at Raymond James » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
FSV

FirstService

$155.11 /

-4.25 (-2.67%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSV FirstService
$155.11 /

-4.25 (-2.67%)

FSV FirstService
$155.11 /

-4.25 (-2.67%)

04/28/21 Raymond James
Raymond James downgrades FirstService to Market Perform on 'healthy valuation'
04/28/21 Raymond James
FirstService downgraded to Market Perform from Outperform at Raymond James
04/28/21
Fly Intel: Top five analyst downgrades
04/28/21 TD Securities
FirstService downgraded to Hold from Buy at TD Securities
FSV FirstService
$155.11 /

-4.25 (-2.67%)

Hot Stocks
Axalta Coating names Keith Silverman to lead Operations and Supply Chain » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
AXTA

Axalta Coating

$30.30 /

-0.195 (-0.64%)

Axalta Coating appointed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

10/12/21 Mizuho
Axalta Coating initiated with a Buy at Mizuho
09/30/21 Deutsche Bank
Deutsche sees earnings risk for PPG, Axalta after Sherwin-Williams cut
09/21/21 RBC Capital
Axalta Coating price target lowered to $36 from $38 at RBC Capital
09/15/21 BofA
Axalta Coating removed from US 1 List at BofA
AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

AXTA Axalta Coating
$30.30 /

-0.195 (-0.64%)

Recommendations
Stifel recommends buying Papa John's shares at current levels » 07:48
01/24/22
01/24
07:48
01/24/22
07:48
PZZA

Papa John's

$114.48 /

-0.21 (-0.18%)

Stifel analyst Chris…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

01/07/22 Oppenheimer
Chipotle upgraded to Outperform at Oppenheimer with stock down 17% from high
01/07/22 Stephens
Stephens says Papa John's China deal may be 'meaningful addition' to unit growth
11/12/21 Benchmark
Papa John's initiated with a Buy at Benchmark
11/05/21
Fly Intel: Top five analyst downgrades
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

  • 20
    Aug
PZZA Papa John's
$114.48 /

-0.21 (-0.18%)

Recommendations
Carvana price target lowered to $165 from $260 at JPMorgan » 07:47
01/24/22
01/24
07:47
01/24/22
07:47
CVNA

Carvana

$135.65 /

-22.12 (-14.02%)

JPMorgan analyst Rajat…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

07:17 Today Morgan Stanley
Carvana pullback presents 'highly compelling' risk/reward, says Morgan Stanley
01/21/22 Wedbush
Carvana price target lowered to $185 from $300 at Wedbush
01/20/22 KeyBanc
KeyBanc more cautious on Carvana, downgrades to Sector Weight
01/20/22 KeyBanc
Carvana downgraded to Sector Weight from Overweight at KeyBanc
CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

CVNA Carvana
$135.65 /

-22.12 (-14.02%)

Upgrade
Colliers International upgraded to Strong Buy from Outperform at Raymond James » 07:46
01/24/22
01/24
07:46
01/24/22
07:46
CIGI

Colliers International

$137.64 /

-2.25 (-1.61%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

12/13/21 National Bank
Colliers International initiated with an Outperform at National Bank
10/26/21 RBC Capital
Colliers International price target raised to $185 from $160 at RBC Capital
10/14/21 Scotiabank
Colliers price target raised to $165 from $152 at Scotiabank
02/16/21 TD Securities
Colliers International price target raised to $125 from $100 at TD Securities
CIGI Colliers International
$137.64 /

-2.25 (-1.61%)

Recommendations
VF Corp. price target lowered to $80 from $90 at JPMorgan » 07:45
01/24/22
01/24
07:45
01/24/22
07:45
VFC

VF Corp.

/

+

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
VFC VF Corp.
/

+

VFC VF Corp.
/

+

01/20/22 Goldman Sachs
VF Corp. price target lowered to $68 from $71 at Goldman Sachs
01/20/22 Williams Capital
VF Corp. downgraded to Hold from Buy at Williams Capital
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
VF Corp. initiated with a Neutral at Seaport Global
VFC VF Corp.
/

+

VFC VF Corp.
/

+

VFC VF Corp.
/

+

Recommendations
Under Armour price target lowered to $28 from $32 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
UAA

Under Armour

$18.77 /

+0.26 (+1.40%)

, UA

Under Armour

$16.08 /

+0.11 (+0.69%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

01/21/22 Citi
Under Armour upgraded to Buy from Neutral at Citi
01/19/22 Exane BNP Paribas
Under Armour upgraded to Neutral from Underperform at Exane BNP Paribas
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/18/22 Seaport Global
Under Armour initiated with a Neutral at Seaport Global
UA Under Armour
$16.08 /

+0.11 (+0.69%)

01/21/22 Citi
Under Armour upgraded to Buy from Neutral at Citi
01/19/22 Exane BNP Paribas
Under Armour upgraded to Neutral from Underperform at Exane BNP Paribas
01/18/22 Seaport Global
Seaport lists Nike, Foot Locker among Buys in Apparel/Footwear sector
01/17/22 BMO Capital
Under Armour upgraded to Outperform from Market Perform at BMO Capital
UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

UAA Under Armour
$18.77 /

+0.26 (+1.40%)

UA Under Armour
$16.08 /

+0.11 (+0.69%)

Recommendations
Ralph Lauren price target lowered to $120 from $122 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
RL

Ralph Lauren

/

+

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
12/15/21 Truist
Truist starts Ralph Lauren at Buy, sees stage set for 'healthier growth'
12/15/21 Truist
Ralph Lauren initiated with a Buy at Truist
12/14/21
Fly Intel: Top five analyst downgrades
RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

RL Ralph Lauren
/

+

Upgrade
Stantec upgraded to Strong Buy from Outperform at Raymond James » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
STN

Stantec

$52.08 /

-0.98 (-1.85%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STN Stantec
$52.08 /

-0.98 (-1.85%)

STN Stantec
$52.08 /

-0.98 (-1.85%)

01/05/22 National Bank
Stantec price target raised to C$80 from C$72 at National Bank
11/08/21 Desjardins
Stantec price target raised to C$81 from C$75 at Desjardins
10/25/21 Desjardins
Stantec price target raised to C$75 from C$66 at Desjardins
10/25/21 Stifel
Stantec price target raised to C$79 from C$70 at Stifel
STN Stantec
$52.08 /

-0.98 (-1.85%)

Recommendations
Levi Strauss price target lowered to $31 from $35 at JPMorgan » 07:44
01/24/22
01/24
07:44
01/24/22
07:44
LEVI

Levi Strauss

$21.36 /

+0.07 (+0.33%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

01/14/22 BofA
BofA trims Levi Strauss price to $30 as coverage transferred
01/07/22 Evercore ISI
Evercore shifts portfolio to 'value oriented' retail names for 2022
01/03/22 Guggenheim
Nike remains a 'Best Idea' at Guggenheim heading into 2022
08/30/21
Fly Intel: Top five analyst initiations
LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

LEVI Levi Strauss
$21.36 /

+0.07 (+0.33%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.